Quantitative imaging of cell-permeable magnetic resonance contrast agents using X-ray fluorescence

Molecular Imaging

Volumn 5, Issue 4, 2006, Pages 485-497

  Endres, Paul J ^a   MacRenaris, Keith W ^a   Vogt, Stefan ^a   Allen, Matthew J ^a   Meade, Thomas J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PATTERNING; CELLULAR TRANSDUCTION MOIETY; DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA); STILBENE;

CELL MEMBRANES; CHEMICAL ANALYSIS; DIAGNOSIS; FLUORESCENCE; MAGNETIC RESONANCE IMAGING; MAPPING; SYNTHESIS (CHEMICAL); X RAY ANALYSIS;

CONTRAST MEDIA;

CHELATING AGENT; CONTRAST MEDIUM; GADOLINIUM 1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETATE; GADOLINIUM PENTETATE; GADOTERIC ACID; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ANIMAL; ARTICLE; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL STRAIN 3T3; CHEMISTRY; DOG; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; SPECTROMETRY; SYNTHESIS;

ANIMALS; CELL LINE; CELL MEMBRANE PERMEABILITY; CHELATING AGENTS; CONTRAST MEDIA; DOGS; GADOLINIUM DTPA; HETEROCYCLIC COMPOUNDS; MAGNETIC RESONANCE IMAGING; MICE; NIH 3T3 CELLS; ORGANOMETALLIC COMPOUNDS; SPECTROMETRY, X-RAY EMISSION;

EID: 33846453577     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2006.00026     Document Type: Article

References (42)

1. Toga AW, Mazziotta JC. Brain mapping: the methods. San Diego (CA): Academic Press; 2002.
2. Allen MJ, MacRenaris KW, Venkatasubramanian PN, Meade TJ. Cellular delivery of MRI contrast agents. Chem Biol 2004;11:301-7.
3. Merbach AE, Toth E. The chemistry of contrast agents in medical magnetic resonance. New York: John Wiley & Sons; 2001.
4. Aime S, Botta M, Terreno E. Gd(III)-based contrast agents for MRI. Adv Inorg Chem 2005;57:173-237.
5. Allen MJ, Meade TJ. Magnetic resonance contrast agents for medical and molecular imaging. In: Sigel A, Sigel H, editors. Metal ions in biological systems. New York: Marcel Dekker; 2004, p. 1-28.
6. Brown MA, Semelka RC. MRI basic principles and applications. New York: Wiley-Liss; 1999.
7. Torchilin V, Babich J, Weissig V. Liposomes and micelles to target the blood pool for imaging purposes. J Liposome Res 2000;10:483-99.
8. Kresse M, Wagner S, Pfefferer D, et al. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magn Reson Med 1998;40:236-42.
9. Moore A, Josephson L, Bhorade RM, et al. Human transferrin receptor gene as a marker gene for MR imaging. Radiology 2001;221:244-50.
10. Kayyem JF, Kumar RM, Fraser SE, Meade TJ. Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem Biol 1995;2:615-20.
11. Konda SD, Aref M, Wang S, et al. Specific targeting of folatedendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magn Reson Mater Phys 2001;12:104-13.
12. Sun C, Veiseh O, Kohler N, et al. Intracellular uptake of folate receptor targeted superparamagnetic nanopartides for enhanced tumor detection by MRI. In: NSTI Nanotech 2005, NSTI Nanotechnology Conference and Trade Show, Anaheim, CA, United States, May 8-12, 2005. Cambridge, MA: Nano Science and Technology Institute; 2005;1:74-7.
13. Reddy JA, Allagadda VM, Leamon CP. Targeting therapeutic and imaging agents to folate receptor positive tumors. Curr Pharm Biotechnol 2005;6:131-50.
14. Futaki S, Suzuki T, Ohashi W, et al. Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001; 276:5836-40.
15. Allen MI, Mcade TJ. Synthesis and visualization of a membrane-permeable MRI contrast agent. J Biol Inorg Chem 2003;8:746-50.
16. Futaki S, Goto S, Sugiura Y. Membrane permeability commonly shared among arginine-rich peptides. J Mol Recognit 2003;16:260-4.
17. Futaki S. Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv Drug Deliver Rev 2005;57:547-58.
18. Kaplan IM, Wadia JS, Dowdy SF. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 2005;107:571-2.
19. Lewin M, Carlesso N, Tung C-H, et al. TAT peptide-derivatized magnetic nanopartides allow in vivo tracking and recovery of progenitor cells, Nat Biotechnol 2000;18:410-4.
20. Torchilin V, Rammohan R, Weissig V, Levchenko T. TAT-peptide attached to the liposome surface strongly facilitates the internalization of liposomes at various conditions. In: Proceedings of the 28th International Symposium on Controlled Release of Bioactive Materials and 4th Consumer & Diversified Products Conference, San Diego, CA, United States, June 23-27, 2001. Minneapolis MA: Controlled Release Society; 2001;1:486-7.
21. Jenkins R, Gedcke D, Gould RW, Quantitative x-ray spectrometry. 2nd ed. New York: Marcel Dekker; 1995.
22. Beekman Freek J, McElroy David P, et al. Towards in vivo nuclear microscopy: iodine-125 imaging in mice using micro-pinholes. Eur J Nucl Med Mol Imaging 2002;29:933-8.
23. Jarver P, Langel U. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov Today 2004;9:395-402.
24. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999;99:2293-352.
25. Allen MI. Delivery and activation of contrast agents for magnetic resonance imaging. Pasadena, CA: California Institute of Technology; 2004.
26. Corson DT, Meares CF. Efficient multigram synthesis of the bifunctional chelating agent (S)-1-p-isothiocyanatobenzyl-diethy-lenetriamine pentaacetic acid. Bioconjug Chem 2000;11:292-9.
27. Takenouchi K, Tabe M, Watanabe K, et al. Novel pendant-type macrocydic bifunctional chekting agents: (carboxymethyl)amino derivatives of 2-(4-nitrobenzyl)-1,4,7,10-tetraazacyclododecaneN,N′,N″, N‴-tetraacetic acid and their complex formation with yttrium(III). J Org Chem 1993;58:6895-9.
28. Freshney I. Culture of animal cells: a manual of basic technique. 4th ed. New York: John Wiley and Sons; 2000.
29. Vogt S. MAPS: a set of software tools for analysis and visualization of 3D X-ray fluorescence data sets. J Phys IV Proc 2003;104:635-8.
30. Fuchs SM, Raines RT. Pathway for polyarginine entry into mammalian cells. Biochemistry 2004;43:2438-44.
31. Skovronsky DM, Zhang B, Kung M-P, et al. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2000;97:7609-14.
32. Kung HF, Lee C-W, Zhuang Z-P, et al. Novel stilbenes as probes for amyloid plaques. I Am Chem Soc 2001:123:12740-41.
33. Jainchill IL, Aaronson SA, Todaro GJ. Marine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J Virol 1969;4:549-53.
34. Gaush CR, Hard WL, Smith TF. Characterization of an established line of canine kidney cells (MDCK). Proc Soc Exp Biol Med 1966;122:931-5.
35. Ralph P, Nakoinz I. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. I Immunol 1977;119:950-4.
36. American Type Culture Collection, Available at: http://www.atcc.org/ (accessed January 2, 2006).
37. Di Fabrizio E, Romanato F, Gentill M, et al. High-efficiency multilevel zone plates for key X-rays. Nature (Lond) 1999;401:895-8.
38. Yun W, Lai B, Cai Z, et al. Nanometer focusing of hard x rays by phase zone plates. Rev Sci Instrum 1999;70:2238-41.
39. Twining B, Baines S, Fisher N, et al. Quantifying trace elements in individual aquatic protist cells with a synchrotron x-ray fluorescence microprobe. Anal Chem 2003;75:3806-16.
40. Al-Taei S, Penning NA, Simpson JC, et al. Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors. Bioconjug Chem 2006;17:90-100.
41. Misfeldt DS, Hamamoto ST, Pitelka DR. Transepithelial transport in cell culture. Proc Natl Acad Sci U S A 1976;73:1212-6.
42. Irvine JD, Takahashi L, Lockhart K, et al. MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J Pharm Sci 1999;88:28-33.